The prenatal origins of lung cancer. II. The placenta

Area of Science:

• Perinatal epidemiology
• Cancer etiology
• Developmental origins of health and disease

Background:

• Birth size relative to weight is a predictor of later lung cancer risk.
• Fetal development, particularly antioxidant systems, may be influenced by maternal-placental nutrient transfer.
• Maternal and placental characteristics are potential determinants of fetal growth and long-term health outcomes.

Purpose of the Study:

• To investigate the association between maternal and placental size and lung cancer risk.
• To identify specific maternal-placental-fetal phenotypes linked to lung cancer development.
• To explore the role of placental characteristics in mediating the relationship between birth size and lung cancer.

Main Methods:

• Analysis of two cohorts (n=20,431) with recorded birth and maternal size, placental weight, and surface diameters.
• Follow-up for lung cancer incidence (n=385).
• Statistical analysis to determine hazard ratios for maternal-placental phenotypes and placental surface area in relation to lung cancer.

Main Results:

• Three distinct maternal-placental-fetal phenotypes were associated with lung cancer.
• Common features included a short mother and a newborn short for their weight.
• Both small and large placental surface areas were linked to increased lung cancer risk, with varying hazard ratios depending on the phenotype.

Conclusions:

• Specific maternal and placental phenotypes are associated with increased risk of developing lung cancer later in life.
• These phenotypes likely reflect altered amino acid and glucose transfer to the fetus, impacting development.
• Placental size (both small and large) plays a significant role in these associations, suggesting a complex interplay affecting long-term cancer risk.